Robert James Wills, Director at Oncternal Therapeutics, holds 10.00K shares in Oncternal Therapeutics (Ticker: ONCT), holds 0.00 shares in CymaBay Therapeutics (Ticker: CBAY), holds 15.00K shares in Milestone Pharmaceuticals (Ticker: MIST). Most recently, Robert James Wills Bought ― shares of Oncternal Therapeutics on Apr 10, 2024 for an estimated value of 27.65K.
What is the percentage of profitable transactions made by Robert James Wills?
The percentage of profitable transactions made by Robert James Wills is 27%.
What is the average return per transaction made by Robert James Wills?
The average return per transaction made by Robert James Wills is -17.80%.
What stocks does Robert James Wills hold?
Robert James Wills holds: ONCT, MIST, CBAY stocks.
What was Robert James Wills’s latest transaction?
Robert James Wills latest transaction was an Informative Buy of $27.65K.
What was Robert James Wills's most profitable transaction?
Robert James Wills’s most profitable transaction was an Informative Buy of CBAY stock on September 9, 2016. The return on the trade was 155.30%.
What is Robert James Wills's role in Oncternal Therapeutics?
Robert James Wills's role in Oncternal Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.